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Rat liver plasma membranes are enriched in a Ca 2+-dependent phosphodiesterase active on phosphatidyli- 
nositol 4,5-P2 and phosphatidylinositol 4-P, but not phosphatidylinositol. Inositol-Pg is the first product of 
the reaction, but is rapidly degraded. Micromolar concentrations of GTP and its nonhydrolyzable 
analogues timulate the reaction, whereas GDP, GMP and other nucleoside triphosphates are inactive. GTP 
and its analogues decrease the requirement of the reaction for Cal+ and also increase its activity at saturating 
Ca2+. These results support the hypothesis that guanine nucleotides and a guanine nucleotide binding 
regulatory protein are involved in coupling the receptors for Ca 2+-mediated agonists to the breakdown of 
plasma membrane phosphatidylinositol 4,5-P2. 
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1, INTRODUCTION 
Many hormones and neurotransmitters exert 
their effects by mobilizing Ca2+ in their target 
cells. This mobilization coincides with IP3 forma- 
tion from PIP2 [1,2], and IP3 releases Ca2+ from 
endoplasmic reticulum when added to permeabi- 
lized cells or isolated organelles [ 1,2]. 
Various reports have shown hormone effects on 
phosphoinositide hydrolysis in liver plasma mem- 
branes [3-61, but the significance of these observa- 
tions remains questionable since most have dealt 
with PI hydrolysis [4-61 whereas hormonal effects 
on inositol phosphates are primarily due to 
breakdown of PIP2 [1,2]. Here, we describe a 
Abbreviations: IP3, myo-inositol trisphosphate; IPI, 
myo-inositol bisphosphate; IP, myo-inositol phosphate; 
PI, phosphatidylinositol; PIP, phosphatidylinositol 
4-phosphate; PIP2, phosphatidylinositol 4,5bisphos- 
phate; GTPrS, guanosine 5’-0-(thiotriphosphate); 
GMPPNP, guanyl-5’-yl imidodiphosphate; GMPPCP, 
guanyl-5 ’ -yl@,y-methylene)diphosphonate 
calcium-sensitive PIP2 phosphodiesterase activity 
that is enriched in liver plasma membranes. This 
activity is stimulated by guanine nucleotides sug- 
gesting that it may be regulated by a guanine 
nucleotide binding protein. 
2. MATERIALS AND METHODS 
Rats were injected intraperitoneally with 
500&i of myo-[2-3H]inositol 18-20 h prior to 
preparation of liver plasma membranes [7] with in- 
clusion of leupeptin and antipain (20pg/ml each) 
in the isolation medium. The membrane pellet was 
resuspended in 10 mM Na+/Hepes, pH 7.5, 1 mM 
EGTA and lOOpg/ml each of leupeptin and anti- 
pain (Transformation Research). Membranes (ap- 
prox. 0.4 mg protein) were incubated at 30°C for 
5 min with the indicated additions in a total of 
0.4 ml. Incubations were stopped with 1.5 ml 
chloroform : methanol (1: 2, v/v) for determina- 
tion of phosphoinositides or with 0.6 ml of 25% 
(w/v) trichloroacetic acid for determination of in- 
ositol phosphates. Phospholipids were extracted 
[8], dried and deacylated [9], and the water-soluble 
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glycero derivatives separated on 2-ml anion ex- 
change columns [lo]. Labeled inositol phosphates 
were determined from the trichloroacetic acid 
supernatants according to Berridge [lo] for in- 
dividual inositol phosphates, or by counting the 
diethyl ether-extracted aqueous phases for total in- 
ositol phosphates. 
[32P]IP3 was prepared as described by Downes 
and Michell [ll]. myo-[2-3H]Inositol was from 
American Radiolabeled Chemicals. Guanine 
nucleotides were from Boehringer 
Sigma. 
3. RESULTS AND DISCUSSION 
Fig.lA shows that when liver 
Mannheim or 
plasma mem- 
branes prepared from rats injected 18-20 h 
previously with myo-[2-3H]inositol were incubated 
in the presence of Ca2+, there was a time- 
dependent reduction in PIP2 radioactivity. PI 
radioactivity was unchanged in the presence or 
absence of Ca2+, and labeling of PIP was minimal 
and showed little change. 
Analysis of the water-soluble products showed a 
rapid accumulation of IP3 and minimal release of 
myo-inositol or other inositol phosphates, when 
the membranes were incubated in the presence of 
5 mM pyrophosphate and the absence of Mg2+ 
(fig. 1B). The formation of IP3 was completely sup- 
pressed by the addition of EGTA. When the in- 
cubations were carried out in the presence of 
10 mM MgCl2 and the absence of pyrophosphate, 
only transient increases in IP3 and IP2 were ob- 
served and most of the label was in the inositol 
fraction at later times (not shown). The effects of 
Mg2+ and pyrophosphate were attributable to 
stimulation and inhibition, respectively, of IP3 
phosphatase activity as shown by studying the 
hydrolysis of exogenous [“P]IP3. 
The phosphodiesterase activity exhibited an ap- 
parent K, for free Ca2+ of 100 nM. Studies of its 
subcellular distribution showed that it was en- 
riched 13-fold in the plasma membrane prepara- 
tion compared with 26-fold for 5 ‘-nucleotidase 
and 1-3-fold for markers of other organelles. 
Seyfred and Wells [3] have similarly reported a 
Ca2+-sensitive polyphosphoinositide phosphodi- 
esterase in rat liver plasma membranes. However, 
their preparations were highly contaminated with 
other subcellular organelles and no data were 
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Fig. 1. Calcium-dependent hydrolysis of plasma 
membrane phosphoinositides and release of inositol 
phosphates. Incubations included 5 mM Na pyrophos- 
phate and either 1.0 mM EGTA (open symbols) or 
1 .O mM EGTA plus 1.4 mM CaClz (closed symbols). 
The experiments shown in each panel are representative 
of at least 3. 
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presented regarding plasma membrane recovery of 
the activity. 
The release of water-soluble [3H]inositol-con- 
taining products from membranes was increased 
by GTP and its analogs GTPyS, GMPPNP and 
GMPPCP, but not by GDP, GMP, ATP or CTP 
(fig.2). Analysis of the products showed the 
greatest increases in IP3 and IP2. The stimulation 
by guanine nucleotides occurred at micromolar 
concentrations (fig.3) and was completely depen- 
dent upon Ca2+. Stimulation of inositide release by 
GTPyS was only seen at 1 nM or higher free Ca2+, 
with the greatest-fold stimulation occurring at sub- 
maximal Ca2+ concentrations (fig.3). Experiments 
with GTP and GMPPNP gave similar results. Ad- 
dition of 0.1 mM GTP to labeled membranes 
caused a 15% decrease in PIP2 radioactivity, which 
was not seen in the presence of EGTA. The 
stimulation of inositide release by guanine 
nucleotides was time dependent, requiring 
5-10 min for maximal stimulation. Guanine 
nucleotides acted by decreasing the Ca2+ require- 
ment of the phosphodiesterase as well as increasing 
its activity at maximal Ca2+ (fig.3). 
Other recent evidence has suggested a role for 
guanine nucleotides in calcium-mediated re- 
sponses. Introduction of GTP analogues into 
permeabilized mast cells or platelets stimulates 
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Fig.2. Guanine nucleotide stimulation of phosphoinosi- 
tide phosphodiesterase activity. Plasma membranes were 
incubated for 5 min with 140 nM free calcium and 
100 pM of the indicated nucleotides. Phosphocreatine 
(5 mM) and creatine phosphokinase (50 U/ml) were 
included with GTP. Each nucleotide was tested at least 
3 times. 
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Fig.3. Stimulation of calcium-dependent phosphoinosi- 
tide hydrolysis by GTPyS. Plasma membranes were 
incubated with the indicated concentrations of GTP+ 
for 20 min. CaClz was then added to the indicated 
concentrations and the incubation continued for an 
additional 5 min. The experiment is representative of 3. 
secretion in the presence of calcium [ 12,131. Islet- 
activating protein, which inactivates the guanine 
nucleotide binding protein involved in inhibition 
of adenylate cyclase, also suppresses histamine 
release and PIP2 breakdown induced by IgE or 
compound 48/80 in mast cells [14,15] and 
arachidonic acid rele,ase induced by chemotactic 
peptide in neutrophils [16]. 
Our data suggest that the stimulation of PIP2 
phosphodiesterase by GTP and its analogues is 
probably mediated by a guanine nucleotide 
regulatory protein since the effect is observed with 
micromolar concentrations of GTP and with non- 
hydrolysable derivatives of GTP. This gives rise to 
the further suggestion that the receptors for 
Ca2+-mobilizing hormones couple to a guanine 
nucleotide binding protein analogous to the 
adenylate cyclase system. Other evidence sug- 
gesting this comes from experiments showing that 
GTP and its analogues inhibit agonist binding to 
these receptors [17-201, and from studies showing 
that calcium-mediated agonists stimulate guanine 
nucleotide hydrolysis or exchange in certain mem- 
branes [21,22]. 
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Cockcroft and Gomperts [23] utilizing mast cell 
membranes and Litosch et al. [24] using mem- 
branes from blowfly salivary glands have also ob- 
tained evidence of a guanine nucleotide effect on 
PIP2 phosphodiesterase activity, and Litosch et al. 
[24] have presented additional evidence for a hor- 
monal stimulation of phosphodiesterase which is 
potentiated by guanine nucleotides. In studies to 
be reported elsewhere, we have also observed a 
hormonal stimulation of the release of inositol 
phosphates in liver membranes which is poten- 
tiated by GTP. 
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